Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

IDELALISIB vs ILOPROST: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

IDELALISIB vs ILOPROST: Safety Overview

Metric IDELALISIB ILOPROST
Total FAERS Reports 6,862 4,961
Deaths Reported 1,548 2,277
Death Rate 22.6% 45.9%
Hospitalizations 2,962 2,324
Average Patient Age 70.0 yrs 57.9 yrs
% Female Patients 38.4% 70.7%
FDA Approval Date Jul 23, 2014 Aug 7, 2009
Manufacturer Gilead Sciences, Inc. BTG International Inc
Route ORAL INTRAVENOUS
Marketing Status Prescription Discontinued